The sale is expected to close in early December.
Schöttli is a global leader in a number of select medical applications, such as syringes, infusion/transfusion products, diagnostic systems and feminine care items.
“Husky has enjoyed a strong and long-lasting relationship with Schöttli and we have long shared a mutual commitment to quality, technology innovation and customer satisfaction,” said John Galt, Husky’s president and CEO. “Through this acquisition, we will be able to work with the many skilled people at Schöttli as one team to deliver more value to customers, particularly in the medical and closures markets. Our goal is to expand our knowledge, expertise, capacity and global footprint so that we can provide the best possible support to customers in these areas of our business.”
Source: Husky Injection Molding Systems
© FoodBev Media Ltd 2024